Talk to a D&B Advisor
1-800-280-0780
  1. Business Directory
  2. CA
  3. Menlo Park
  4. Medical and Hospital Equipment
  5. Wholesale - Medical Equipment And Supplies
  6. Auxogyn, Inc.

Auxogyn, Inc.

CLAIM THIS BUSINESS

1490 OBRIEN DR MENLO PARK, CA 94025 Get Directions

(650) 325-2382

www.auxogyn.com

Business Info

  • Founded 2008
  • Incorporated CA
  • Annual Revenue $330,000.00
  • Employee Count 2
  • Industries Wholesale - Medical Equipment And Supplies
  • Contacts Lissa Goldenstein

Contact Business

Send Message

Company Summary

Auxogyn is revolutionizing the field of reproductive medicine by translating scientific discoveries in early embryo development into valuable clinical tools. The Company's flagship product, the Eeva(TM) Test, is designed to deliver consistent, objective and quantitative information regarding embryo viability that reproductive endocrinologists and infertility patients can use to make important treatment decisions.

Auxogyn was founded by pioneering scientists from the Stanford University (Professor Renee Reijo Pera, Ph.D. in collaboration with colleagues Dr. Barry Behr, Dr. Thomas Baer, and post-doctoral fellows Dr. Connie Wong and Dr. Kevin Loewke) who conducted landmark research that provided the first link between embryo developmental outcome, cell division events and the molecular health of the embryo. Auxogyn continues to provide new clinical and scientific benchmarks that reproductive endocrinologists and their patients can use when making critical decisions in their journey through infertility treatment.

Auxogyn is privately held and funded by Kleiner Perkins Caufield & Byers, Merck Serono Ventures, SR One (venture capital arm of GlaxoSmithKline), and TPG Biotech.

Auxogyn's first product, the non-invasive Early Embryo Viability Assessment System (Eeva), may improve in vitro fertilization (IVF) outcomes by providing IVF clinics and patients with objective information regarding embryo viability. Eeva's proprietary software automatically analyzes embryo development against scientifically and clinically validated cell-division timing parameters. With Eeva's quantitative data describing each embryo's development, IVF clinics may improve the treatment path for their patients undergoing IVF procedures.

In addition to Eeva, Auxogyn is committed to developing other innovative products to address the growing number of patients suffering from infertility today.

VERIFIED Status: UNVERIFIED
Address:
UNVERIFIED
LAST VERIFIED: --
Phone:
UNVERIFIED
Payment Method:
UNVERIFIED
view full report

Similar Businesses Nearby

Our similar businesses nearby shows similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.

    Competitive Landscape

    Our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their Dun & Bradstreet Credibility Review profile.

      Payments Accepted

        NO DATA

      Hours

      • Sunday  --
      • Monday  --
      • Tuesday  --
      • Wednesday  --
      • Thursday  --
      • Friday  --
      • Saturday  --
      VIEW ADDITIONAL DATA Select from over 115 networks below to view available data about this business. If this data is unavailable or inaccurate and you own or represent this business, click here for more information on how you may be able to correct it.

      Business Credit Report

      Receive a one-time comprehensive credit report on this company.
      get full credit report
      Chat With Us LiveCall 1.800.280.0780 to speak with a D&B Advisor Today!